Molecular imaging of fibroblast activity in pressure overload heart failure using [68Ga]Ga-FAPI-04 PET/CT.

Abstract

We aimed to evaluate whether [68Ga]Ga-FAPI-04 PET/CT could characterize the early stages of cardiac fibrosis in pressure overload heart failure. Sprague-Dawley rats underwent abdominal aortic constriction (AAC) (n = 12) and sham surgery (n = 10). All rats were scanned with [68Ga]Ga-FAPI-04 PET/CT at 2, 4, and 8weeks after surgery. The expression of fibroblast activation protein (FAP) in the myocardium was detected by immunohistochemistry. [68Ga]Ga-FAPI-04 PET signal and FAP expression were compared between two groups. Compared with the sham group, the AAC group presented with decreased ejection fraction (EF) and fractional shortening (FS) and increased left ventricular internal dimensions in diastole (LVIDd) and systole (LVIDs) at 4 and 8weeks (all p < 0.01). The AAC group showed higher [68Ga]Ga-FAPI-04 accumulation in the heart than the sham group at 2, 4, and 8weeks, and FAPI increased significantly from 2 to 8weeks (all p < 0.001). Immunohistochemistry confirmed the higher density of the FAP+ area in the AAC group. The intensity of the [68Ga]Ga-FAPI-04 correlated with the density of the FAP+ area (p < 0.001). The expression of the [68Ga]Ga-FAPI-04 at 4weeks correlated with the deterioration of cardiac function at 8weeks (EF: R = - 0.87; FS: R = - 0.72; LVIDd: R = 0.77; LVIDs: R = 0.79; all p < 0.001). The AAC group also showed an increased [68Ga]Ga-FAPI-04 signal in the liver, peaking at 4weeks and then declining. Cardiac and liver PET signals correlated at 4weeks in the AAC group (R = 0.69, p = 0.0010), suggesting an early fibrotic link between organs. A combination of the [68Ga]Ga-FAPI-04 intensity in the heart and liver at 4weeks better predicted the deterioration of cardiac function at 8weeks. The activated fibroblasts in the heart and liver after pressure overload can be monitored by [68Ga]Ga-FAPI-04 PET/CT, which reveals an early fibrotic link in cardio-liver interactions and could better predict nonischemic heart failure prognosis.